Medical business partnership with Sewoon Medical. (20 Nov, 2000)
페이지 정보
작성자 ㈜MST 조회894 View 작성일 11-02-14 09:25본문
Medical business partnership with Sewoon Medical. (20 Nov, 2000)
We, MST(KOREA) CO., LTD.(CEO Woong-Sig Moon·www.BioCleanAct.com·BrandName: BioCleanAct™) has made strategic Medical product business partnership contract with Sewoon Medical Co., Ltd. (called Sewoon) who is a specialized company in manufacturing of medical products, eq silicon catheter, rubber products, etc. on 11th Nov, 2000.
Mst, as thecondition of an exclusive sale, supplies non-toxic antimicrobial agent (BrandName : BioCleanAct™) to Sewoon and Sewoon manufactures non-toxic antimicrobial medical products, eq silicon, rubber, etc by incorporating with BioCleanAct™ and sells in domestic and oversea market and provides royalty and indicated amount for using this technology to MST.
As a result of this contract, Sewoon will manufacture non-toxic antimicrobial medical products (called bio-medical products) to prevent the secondary infection of microorganisms of the patients in having an operation.
The bio-medical products will be excellent and remarkable product differentiated from conventional medical products in global market.
BioCleanAct™ which will be provided to Sewoon is completely differentiated from conventional antimicrobial agents (eq, biocides), that is it is completely non-toxic antimicrobial agent, and its non-toxicity and antimicrobial efficacy have already been testified by a leading laboratory in the US registered from FDA.
Sewoon has distributed medical products in domestic large general hospitals and already acquired ISO 9001, EN 46001, CEO 120 (England, S.G.S. TARSLEY) to export to the developed countries market including european market.
